Research Analyst at Eight Capital
Ty Collin is an Equity Research Analyst at Eight Capital, specializing in the cannabis sector with notable coverage of companies such as Canopy Growth, Curaleaf Holdings, and Green Thumb Industries. He is recognized for his assertive investment calls, including issuing a $0 price target on Canopy Growth, and is cited for his in-depth sector research and informed views on US versus Canadian cannabis equities. Collin began his analyst career at Eight Capital and has been active in the industry for multiple years, establishing his expertise through detailed company analysis and conference call participation. His professional credentials include experience in institutional equity research, with a track record of delivering high-conviction insights on major North American cannabis operators.
Ty Colin of Eight Capital questioned the risk of consumers returning to the illicit market for lower prices, particularly in high-tax states like Illinois and New Jersey.
CEO Ben Kovler stated that the company does not see a trade-down from legal to illegal markets as a major factor. He argued the price premium for safe, tested, and branded products is not significant and cited strong July sales data in Illinois as evidence of sustained legal market demand.
Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.
Trusted by leading investment firms and analysts